Company intelligence / Profile preview

Timeless

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Timeless is a biotechnology and health technology company focused on the science of longevity and healthy aging. The company leverages insights into the TIMELESS gene and circadian rhythm biology to develop therapeutic interventions and diagnostic tools aimed at extending human healthspan. By integrating advanced data analytics with molecular biology, Timeless seeks to identify biomarkers of aging and develop personalized longevity protocols. Their approach combines traditional drug discovery with digital health solutions to provide a comprehensive ecosystem for proactive health management.

Therapeutic areas: NeurologyOtherMetabolic Disorders
Modalities: Small moleculeBiologicDigital health
Industry: Biotech

Beyond the preview

Go deeper on Timeless.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Timeless.

Explore the full profile